Finoriq

Finoriq research workspace

Armata Pharmaceuticals, Inc. (ARMP) SEC Filings & Filing Highlights

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on. Review ARMP SEC filings, filing highlights, and disclosure activity on Finoriq.

Company Snapshot

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.

Company
Armata Pharmaceuticals, Inc. (ARMP)
Ticker
ARMP
Market Cap
$183.6M
Latest Price
$5.00
Industry
Biotech & Pharma

Open insider transactions

Armata Pharmaceuticals, Inc. (ARMP) Recent SEC Filing Highlights

Recent SEC filings, filing events, and disclosure highlights indexed for Armata Pharmaceuticals, Inc. (ARMP).

EventFormDate
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from theArmata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the8-K8.012026-06-23
Number of Shares Voted ForAt the Annual Meeting of Shareholders held on June 11, 2026 (the “Meeting”), the shareholders of Armata Pharmaceuticals, Inc. (the “Company...8-K5.072026-06-16
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate UpdateArmata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update8-K7.012026-05-13
Debt or FinancingDebt or Financing8-K2.032026-05-13
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate UpdateArmata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update8-K2.022026-05-13

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.